Home » Novartis Temporarily Powers Down OTC Plant After Form 483
Novartis Temporarily Powers Down OTC Plant After Form 483
Novartis has temporarily shuttered its Lincoln, Neb., OTC drug plant after being hit with a 13-page Form 483 noting a “pattern of problems” with investigations into foreign tablets in product batches.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May